Christoph Samuel Ziegler insider trades: Veraxa Biotech AG - Post de-SPAC (VRXA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Christoph reports to the SEC
Open-market buys and sales
1 trade reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Oct 20, 2026 | VRXA | ↑ Buy | 30,000 | $1.09 | $33K | Direct | Oct 21, 2026 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other VRXA insiders
Open-market trades in the last 12 months
About Christoph Samuel Ziegler's insider trades
Christoph Samuel Ziegler is a director at Veraxa Biotech AG - Post de-SPAC (VRXA). Since Oct 20, 2026, Christoph has reported 1 open-market purchase worth $33K and no sales on SEC Form 4. In the last 12 months: 1 buy ($33K).
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VRXA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.